Treatment of metastatic melanoma patients with tumor infiltrating lymphocytes and IL [interleukin]-2 following a regimen of non-myeloablative lymphocyte depleting chemotherapy
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Fludarabine; Interleukin-2
- Indications Malignant melanoma
- Focus Therapeutic Use
- 18 Sep 2018 Biomarkers information updated
- 03 Mar 2008 New trial record.